Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients

被引:5
|
作者
Bosas, Paulius [1 ]
Zaleskis, Gintaras [2 ]
Dabkeviciene, Daiva [2 ]
Dobrovolskiene, Neringa [2 ]
Mlynska, Agata [2 ,3 ]
Tikuisis, Renatas [2 ]
Ulys, Albertas [2 ]
Pasukoniene, Vita [2 ,3 ]
Jarmalaite, Sonata [2 ,4 ]
Jankevicius, Feliksas [1 ,5 ]
机构
[1] Vilnius Univ, Fac Med, Inst Clin Med, LT-03101 Vilnius, Lithuania
[2] Natl Canc Inst Lithuania, LT-08406 Vilnius, Lithuania
[3] Vilnius Gediminas Tech Univ, Dept Chem & Bioengn, LT-10223 Vilnius, Lithuania
[4] Vilnius Univ, Life Sci Ctr, Inst Biosci, LT-10257 Vilnius, Lithuania
[5] Vilnius Univ Hosp Santaros Klin, LT-08661 Vilnius, Lithuania
关键词
prostate cancer; prostatectomy; biochemical recurrence; immunophenotyping; ASSISTED RADICAL PROSTATECTOMY; KILLER-CELL ACTIVITY; SUPPRESSOR-CELLS; IMMUNE-RESPONSE; RADIOTHERAPY; LAPAROTOMY; EXPRESSION; GENERATION; RESECTION; OUTCOMES;
D O I
10.3390/jcm10163709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical recurrence (BCR) in high risk (HR) and low risk (LR) patients. Methods: Radical prostatectomy (RP) was performed on 108 PCa stage pT2-pT3 patients. Preoperative vs. postoperative (one and three months) immunophenotype profile (T- and B-cell subsets, MDSC, NK, and T reg populations) was compared in peripheral blood of LR and HR groups. Results: The BCR-free survival difference was significant between the HR and LR groups. Postoperative PSA decay rate, defined as ePSA, was significantly slower in the HR group and predicted BCR at cut-off level ePSA = -2.0% d(-1) (AUC = 0.85 (95% CI, 0.78-0.90). Three months following tumor excision, the LR group exhibited a recovery of natural killer CD3 - CD16+ CD56+ cells, from 232 cells/mu L to 317 cells/mu L (p < 0.05), which was not detectable in the HR group. Prostatectomy also resulted in an increased CD8+ population in the LR group, mostly due to CD8+ CD69+ compartment (from 186 cells/mu L before surgery to 196 cells/mu L three months after, p < 001). The CD8+ CD69+ subset increase without total T cell increase was present in the HR group (p < 0.001). Tumor excision resulted in a myeloid-derived suppressor cell (MDSC) number increase from 12.4 cells/mu L to 16.2 cells/mu L in the HR group, and no change was detectable in LR patients (p = 0.12). An immune signature of postoperative recovery was more likely to occur in patients undergoing laparoscopic radical prostatectomy (LRP). Open RP (ORP) was associated with increased MDSC numbers (p = 0.002), whereas LRP was characterized by an immunity sparing profile, with no change in MDSC subset (p = 0.16). Conclusion: Tumor excision in prostate cancer patients results in two distinct patterns of immunophenotype rearrangement. The low-risk group is highly responsive, revealing postoperative restoration of T cells, NK cells, and CD8+ CD69+ numbers and the absence of suppressor MDSC increase. The high-risk group presented a limited response, accompanied by a suppressor MDSC increase and CD8+ CD69+ increase. The laparoscopic approach, unlike ORP, did not result in an MDSC increase in the postoperative period.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] ERG Rearrangement Is Associated with Prostate Cancer-Related Death in Chinese Prostate Cancer Patients
    Qi, Mei
    Yang, Xiaoqing
    Zhang, Fan
    Lin, Tao
    Sun, Xiubin
    Li, Yanjiang
    Yuan, Huiqing
    Ren, Yubo
    Zhang, Juan
    Qin, Xiaomin
    Han, Bo
    PLOS ONE, 2014, 9 (02):
  • [32] Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival
    Chung, Benjamin I.
    Tarin, Tatum V.
    Ferrari, Michelle
    Brooks, James D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (03) : 314 - 318
  • [33] Characteristics and risk factors of biochemical recurrence after radical prostatectomy in patients with prostate cancer
    Duan, Guanglan
    Wang, Changmei
    Ma, Caihong
    Zhang, Huiming
    Wei, Jinxing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 5320 - 5325
  • [34] Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naive patients
    Heo, Ji Eun
    Park, Jee Soo
    Lee, Jong Soo
    Kim, Jongchan
    Jang, Won Sik
    Cho, Nam Hoon
    Rha, Koon Ho
    Choi, Young Deuk
    Hong, Sung Joon
    Ham, Won Sik
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 221 - 227
  • [35] Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer
    Khan, Saira
    Chang, Su-Hsin
    Seyerle, Amanda A. A.
    Wang, Mei
    Hicks, Veronica
    Drake, Bettina F. F.
    PROSTATE, 2023, 83 (12) : 1150 - 1157
  • [36] High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer
    Kurose, Hirofumi
    Naito, Yoshiki
    Akiba, Jun
    Kondo, Reiichiro
    Ogasawara, Sachiko
    Kusano, Hironori
    Sanada, Sakiko
    Abe, Hideyuki
    Kakuma, Tatsuyuki
    Ueda, Kosuke
    Igawa, Tsukasa
    Yano, Hirohisa
    MEDICAL MOLECULAR MORPHOLOGY, 2019, 52 (03) : 164 - 172
  • [37] A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy
    Feng, Dechao
    Shi, Xu
    Xiong, Qiao
    Zhang, Facai
    Li, Dengxiong
    Wei, Wuran
    Yang, Lu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [38] Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy
    Rezaee, Michael E.
    Pallauf, Maximilian
    Fletcher, Sean A.
    Han, Misop
    Pavlovich, Christian P.
    Cornelia Ding, Chien-Kuang
    Epstein, Jonathan I.
    Allaf, Mohamad E.
    Trock, Bruce J.
    Singla, Nirmish
    JOURNAL OF UROLOGY, 2024, 211 (03) : 407 - 414
  • [39] Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study
    Hatano, Koji
    Okusa, Takuya
    Ishizuya, Yu
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Nishimura, Kazuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 74 - 79
  • [40] Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
    Lv, Zhengtong
    Wang, Jianlong
    Wang, Xuan
    Mo, Miao
    Tang, Guyu
    Xu, Haozhe
    Wang, Jianye
    Li, Yuan
    Liu, Ming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9